Publications

Pinzone MRita, D VanBelzen J, Weissman S, Bertuccio MPaola, Cannon LM, Venanzi-Rullo E, Migueles S, R Jones B, Mota T, Joseph SB et al..  2019.  Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.. Nat Commun. 10(1):728.

Clutton GTyndale, R Jones B.  2018.  Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.. Front Immunol. 9:1452.

Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang S-H, Ren Y, Spivak AM, R Jones B, Planelles V et al..  2018.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.. JCI Insight. 3(19)

Osuna CE, Lim S-Y, Kublin JL, Apps R, Chen E, Mota TM, Huang S-H, Ren Y, Bachtel ND, Tsibris AM et al..  2018.  Evidence that CD32a does not mark the HIV-1 latent reservoir.. Nature. 561(7723):E20-E28.

Bachtel ND, Beckerle GA, Mota T, Rougvie Mde Mulder, Raposo RAndre, R Jones B, Nixon DF, Apps R.  2018.  Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART.. AIDS Res Hum Retroviruses.

Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA et al..  2018.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.. PLoS Pathog. 14(9):e1007257.